SCHEMBL4599760

SCHEMBL4599760

C=CCNc1[c]ccc(OS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 4/20 0.38
FAAH O00519 1/20 0.38
MAOB P27338 2/20 0.37
ENPP3 O14638 5/20 0.36
ENPP1 P22413 5/20 0.36
ENPP2 Q13822 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599126 0.88 MEN1 (0.41) ALDH1A1ENPP3ENPP1ENPP2L3MBTL1
SCHEMBL4598688 0.83 TDP1 (0.43) ALDH1A1SMN1; SMN2TDP1FAAHMAOB
SCHEMBL4598731 0.82 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TDP1FAAHMAOB
SCHEMBL4598887 0.82 CA12 (0.35) ALDH1A1FAAHGAAMAPK1CA12
SCHEMBL4611281 0.80 FAAH (0.40) ALDH1A1SMN1; SMN2TDP1FAAHMAOB
SCHEMBL4600500 0.79 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TDP1MAOBENPP3
SCHEMBL4599161 0.76 HTT (0.49) ALDH1A1SMN1; SMN2TDP1L3MBTL1GAA
SCHEMBL4598684 0.75 BCHE (0.43) ALDH1A1MAOBL3MBTL1GAANPC1
SCHEMBL4599999 0.75 L3MBTL1 (0.45) ALDH1A1SMN1; SMN2TDP1ENPP2L3MBTL1
SCHEMBL4599861 0.73 GAA (0.40) ALDH1A1ENPP1ENPP2L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed